Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Management Team:
Benjamin Ward
CEO
Benjamin Ward, CEO, is a management professional with significant experience in infrastructure development and capital markets. Ben has founded three public companies in the United States, and holds a BA (honors), MBA and PMP. Ben is a director of Neue Energy Group, a Munich-based energy company; NexGen Energy, a California-based Company; and Niostar Corporation.
John Esteireiro
COO
John Esteireiro, COO, has over 20 years’ experience in capital markets. He served as Managing Director and Head of Institutional Equity Trading at CIBC world markets. John was a founding partner of Genuity Capital Markets and after it was sold to Canaccord in 2010, he was Managing Director and Head of Canadian Institutional Equity Trading. John has a Bachelor of Commerce from the University of Toronto.
Aubrey Bradley Jr
Master Grower
Aubrey started his career with Universal Lighting Sales in the year 2004 as a Salesman learning what his clients needed and how the lighting industry worked. In 2006, he launched his own lighting company, The Rae Company, Inc., growing to earn major client projects for JW Marriot/Ritz Carlton, Golden West College Library, Aloft Hotel and Element Hotel. In 2010, Aubrey launched Growlite, Inc., a manufacturing company for horticultural lighting and developed the patented Concealed Vacuum Airflow Technology (CVAT).
Today, Aubrey continues to be the CEO of Growlite and is CCC’s Master Grower.
Nate Nienhuis
Chief Horticulturalist Advisor
Before beginning his career in medical marihuana, Nate attended California State University, Fullerton, for mechanical engineering. He worked as Head Engineer for Growlite, Inc. where he helped design grows for the indoor gardening industry. Nate is an experienced indoor, commercial horticulturalist. His expertise expands beyond cultivation and into cultivation centre design and engineering. As Chief Horticulturalist Advisor, Nate expects to utilize his expansive knowledge and unique skill set to create a state-of-the-art production facility that will remain cutting edge in its technology and efficiency, while maintaining true to the spirit of environmental consciousness and general goodwill with Grow Consulting Group, LLC.
Sheldon Aberman
Executive VP, Technology and Product Development
Sheldon started his professional life as a corporate Insurance Analyst working with Fortune 100 companies. However, in 2003, he decided to transform a long time hobby into a dynamic business and took the brave step of operating an indoor gardening store in Chicago. Sheldon’s venture into the hydroponic industry started as a sales representative and quickly climbed the ladder to US Sales Director for a Gotta Grow Wholesale, where he achieved 800% increase in revenues.
In 2007, Sheldon launched his own distribution company--Amerinada. Together with Quantum Horticulture, Amerinada would come to be recognized as quality brand of horticultural lighting products gaining national acceptance throughout the United Sates and eventually would expand operations to Canada, Europe and Australia following continued domestic and foreign growth.
Other ventures, including Frost Box and Pure Essentials Black Label, and Sheldon’s experience designing thousands of grows across the globe, has earned Sheldon a reputation as one of the world’s foremost experts on cannabis cultivation.
Sheldon has been involved with, managed and designed thousands of grows across the globe. His expertise, hands on approach and product development background has led to top quality grow room design centric on business operations, documentable data and redundancies to ensure maximized up time.
As of May 2014, Sheldon continued to operate Pure Essentials Black Label, and joined Grow Consulting Group; LLC where he extends his expansive knowledge through consulting large scale grows. Sheldon has begun consulting and manufacturing OEM products in the accessory market including vape pens, e-cigarettes, silicon mats/dishes as well as extract tools.
Sheldon continues to influence myriad facets of the rapidly expanding world of cannabis now.
John Carroll
VP Operations
John started in horticulture in a small greenhouse in southern Ontario. By age 18, John was responsible for expanding the operation to a facility that was producing 1.5 million tropical plants per year. As a result of this experience, John became proficient in the structural design, electrical design, heating and cooling, as well as sub trade management.
John holds a Commercial Pilots Licence with an Airline Transport Rating and in 2002 joined Transport Canada and was responsible for Regulatory control over 26 Air Service and Airline companies. There, John gained knowledge of Canada’s Federal Government Regulatory process, which has been invaluable to CCC working within Health Canada’s regulatory framework.
John built and operated green energy companies including Solar and LED lighting, and developed his own business in the greenhouse lighting sector leading to the development of Growlite.
John serves as VP of Operations for Canadian Cannabis Corporation and brings a wealth of knowledge and expertise to the changing regulatory environment in Canada.
Our Mission: CCC is committed to creating and producing the highest quality medical marihuana with proven and sustainable practices. We believe medical marihuana is a unique and effective treatment option and will strive to provide all eligible patients with a safe and premium grade product.
Our mission is to unlock the full potential of medical marihuana for those who suffer from a myriad of chronic conditions and to do so safely and in adherence with all regulatory guidelines.
Our Story: http://canadiancannabiscorp.com/our-story-2
•Canadian Cannabis Corp (OTCBB: CCAN) – production of cannabis and related products for distribution to patients in Canada and globally.
•Headquarters – 300,000 sq. ft. facility, with zoning approved for production of medical cannabis. Located 12 miles from Pearson International Airport (YYZ), in the Greater Toronto Area.
•Canadian Cannabis Corp is poised to enter the market as the largest indoor licensed producer in Canada.
•The Company has submitted and is in the review process of its commercial production license to be granted by Health Canada for 330,000 pounds of cannabis produced annually. This will be the largest capacity license when granted.
•Integrated and diversified business model inclusive of finance, grow supplies, cultivation, dose administration devices, and end distribution, CCAN has a robust revenue stream, already revenue positive from a joint venture in the horticultural hydroponic lighting sector.
Gold Party Payday Inc., GPAY, changed to Canadian Cannabis Corp., CCAN:
http://www.otcbb.com/asp/dailylist_detail.asp?d=10/14/2014&mkt_ctg=OTCBB
(Reuters) - U.S. investors in Canada's medical marijuana industry are betting they will not fall under the scrutiny of U.S. law enforcement officers - but it is a risky bet.
http://www.reuters.com/article/2014/10/10/us-canada-marijuana-investors-idUSKCN0HZ0ZY20141010
With marijuana still illegal on a federal level in the United States, American investors in Canadian medical marijuana can be seen as violating the Controlled Substances Act, according to some U.S experts. And the use of the banking system to transfer the proceeds of such investments could be seen as money laundering.
The U.S. Drug Enforcement Administration has already been tracking investments made in state-sanctioned marijuana business in the United States. When asked by Reuters about the DEA's view of U.S. investments in Canadian marijuana, DEA spokesman Rusty Payne said the agency is "most interested in those types of activities."
After the Reuters report, shares in Canadian medical marijuana companies fell sharply at the open before recovering some ground. OrganiGram Holdings Inc (OGI.V) dropped 6.9 percent in early trading, Bedrocan Cannabis Corp (BED.V) fell 4.2 percent and Tweed Marijuana Inc (TWD.V) declined 2.8 percent.
U.S. investors have been increasingly drawn to the raft of public listings by producers that has sprung up since Canada overhauled its laws this year, making it legal to buy marijuana from licensed producers with a doctor’s prescription.
Canada's medical marijuana market, which is expected to grow more than tenfold, to C$1.3 billion, in a decade, has matured more rapidly than its peers. While U.S. investors have several European markets where medical marijuana is legal on their radar - Canada has been the biggest beneficiary of fund flows from U.S. investors.
"We really like the Canada model, which is really unlike any other in the world,” said Christian Groh, a co-founder of Seattle-based private equity firm Privateer Holdings, one of the largest players in the medical marijuana sector. "What we're doing here does not violate local, state and federal law (in Canada)."
Privateer created a Canadian subsidiary as its foothold in the market. Other investors, however, have jumped straight in from their U.S. bases.
Timothy White, national risk specialist for Banker's Toolbox Inc, a firm that helps banks detect and report money laundering, said U.S. investors in Canadian marijuana firms could be violating drug trafficking and money laundering laws.
"That is two violations of U.S. federal law. I don't see there is any way around that," White said.
A former DEA official who asked not to be named said that "at best," the investments are "an extremely reckless thing to do." Investors could face money laundering charges and any return on investment "would have the taint of drug proceeds," the former official said.
"If they sought legal advice on this, they were grossly underserved," the former official said.
There have been no prosecutions by U.S. authorities of investors in Canada, according to legal experts who have been closely following the market.
Payne, the DEA spokesman, said the U.S. agency has "limited investigatory resources" to pursue investors and is most interested in targeting those with deep pockets who pour large sums into the industry.
HIGH HOPES
It is a risk many U.S. investors, eyeing healthy returns, are willing to take. They are counting on shifting attitudes toward marijuana in the United States, and they see scant chances of prosecution under the Obama administration.
"There are so many companies investing in the Canadian side, and this (money-laundering risk) is just not something that is coming up as an issue," said one U.S. investor in the Canadian medical marijuana market who spoke on condition of anonymity.
"You can invest in pharmaceutical companies (whose drugs are not approved) in the United States. This is just another medicine."
Canadian producer OrganiGram has nearly doubled in value since listing on Aug. 25. Meanwhile, Bedrocan was the second-most actively traded stock on the TSX venture exchange on its market debut on the same day.
Roughly 30 percent of OrganiGram’s shares are held by U.S. investors. Other producers also reported high levels of U.S. investment in their shares and capital raising.
Toronto-based PharmaCan Capital, one of the most active investors in the Canadian market and likely to go public itself, said it raised about 35 percent of its capital outside Canada.
So far, only relatively small U.S. investors have been active in Canada's marijuana sector. Deep-pocketed institutional investors in the United States are yet to be swayed, partly because of the legal risks and because the investments available are generally too small to interest them. Then there is the stigma associated with the industry.
Canadian and U.S. investors also have to grapple with the risk of betting in a nascent, unproven market that is still finding its way. Securities regulators on both sides of the border have warned investors to stay clear of speculators.
"The larger institutions have a lot to lose and face a lot of scrutiny because of everything else they do,” said Brian Vicente, a partner at Vicente Sederberg in Denver. "They are not interested in taking that risk at this moment, and that opens up space and opportunities for smaller firms."
Hopes that more U.S. states will follow the lead of Washington and Colorado and approve ballot initiatives that make marijuana legal for adult use have boosted the ranks of investors looking at early stage marijuana-related companies. Twenty-three U.S. states have legalized medical marijuana.
"Some investors look at this and think, 'I'm getting in on the ground floor. I'm going to be part of the next Facebook of marijuana, and timing is everything. ... I can buy in low and eventually sell super-high when legalization hits,' " said Hilary Bricken, a lawyer at Seattle-based Harris Moure. "That day may never come."
(Reporting by John Tilak in Toronto and Brett Wolf of the Compliance Complete service of Thomson Reuters Accelus in St. Louis; Additional reporting by David Randall in New York; Editing by Amran Abocar, Douglas Royalty and Marguerita Choy)
From recent 8-K/A: http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10111927
RECENT SALES OF UNREGISTERED SECURITIES
Immediately after the closing of the Merger Agreement and Transfer Agreement, we sold an aggregate of 6,185 shares of our common stock to investors in a private placement transaction in consideration of an aggregate amount of $361,698 paid by the investors to the Company.
Insiders (private placement) have paid about $60/share for this stock based on my calculations...
There are only 1,300,000 outstanding as of today so it makes sense why the price is so high..Any lower and we would control the float lol (300K shares).
Dividends
Immediately after the closing of the Merger Agreement and Transfer Agreement, our Board of Directors declared a stock dividend of 19.5 shares of our common stock for every share of our common stock held as of the record date of the Closing Date, after taking into effect the stock exchanges and acquisitions effected by the Merger Agreement and Transfer Agreement (the “Stock Dividend”).
Price will come down to about $3 after the 20:1 forward split/name change :)
I know where it is.. I know how much electrical and hvac costs are... It is a lot of money to build one of these facilities so 13M makes sense.
I have no idea about company and people so will watch for now..
I have no idea ... you said it ... it's unrealistic !
Does anyone know what's going on with this company? $20 dollars a share is unrealistic for the average Joe. Is that the real share price? Does anyone have any insight?
Low float for $GPAY
Light volume Friday imo for $GPAY.
Is this a "get in now" play or wait a week or two?
Nah, that's incorrect:
From merger 8-k ( http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10003977 )
Common Stock
The authorized capital stock of our Company consists of 95,000,000 shares of Common Stock, par value $0.000001 per share, of which there are 1,338,289 issued and outstanding immediately after giving effect to the transactions consummated by the Merger Agreement and Transfer Agreement.
Former director cancelled his 4,000,000 shares after the agreement. Current market cap here is like $12M.
Keep in mind the float here is like 300K.
This sucker is set to fly!
Shares Outstanding 4,333,350 - a/o Aug 13, 2013 ???
http://www.otcmarkets.com/stock/GPAY/profile
It has started today ...
Where is these 'production facility' the are talking about ???
Does anybody know ?
Are they related with Vida Cannabis (Canada) Ltd. ?
" ... Today, the Canadian Cannabis Corporation owns and operates the largest cannabis production facility in North America ... "
http://canadiancannabiscorp.com/our-story-2
does anyone know when this starts trading
Don't know but if I find out I'll let u know, very hush hush. CCC is
I wonder how ???
Are shares there shares to buy ??? ... and look at the BID and ASK prize .... hmmm
It's very interesting, Benjiman Ward which is part of JSHG has something going on with CPAY but neither company has trades or volume. Either will be here before it becomes a mad house or they are only wishing that they could get a lic approval in Canada. Going to do some more DD and call both companies on Mon
I wonder why no one is buying this company
New company's website
http://canadiancannabiscorp.com
Canadian Cannabis Company Buys Huge Facility for $13M
The Canadian Cannabis Corp. listed on the NASDAQ as Gold Part Payday Inc. (GPAY), which was founded this year. has announced the purchase of a 300,000-square-foot facility in Brampton ...
... When fully built, the Brampton site is expected to allow a maximum of about 600,000 square feet in production space on two levels. Although the company does not currently intend to build out the entire facility, the company said it expects to revisit plans if demand of medical marijuana justifies expanding production ...
... According to the company’s investment presentation, it is seeking a commercial license to produce 330,000 pounds of cannabis annually ...
http://www.insidehalton.com/news-story/4635280-marijuana-production-firm-buys-brampton-facility/
WoW!!! Everyone is going to try to get in the MMJ business. From buying junk jewelry & coins to MMJ. It takes a lot of hard work and time to even get a seed in the soil. Good Luck!
On April 1, 2014, Canada Cannabis Corp., a predecessor entity to Gold Party Payday Inc.’s (the “Company”) wholly-owned subsidiary Canadian Cannabis Corp. (together with Canada Cannabis Corp., “CCC”), entered into an Agreement of Purchase and Sale (the “Purchase Agreement”) with I.L. Rosen Limited, Time Holdings Limited and Tanak Group Ltd. (collectively, the “Seller”) pursuant to which CCC will purchase from Seller the real property, including an approximately 312,500 square foot industrial building, located at 98-102 Rutherford Road South, Brampton, Ontario (the “Brampton Property”) for a total consideration of CAD $13,400,000 (the “Purchase Price”).
In connection with the Purchase Agreement, on April 3, 2014, CCC paid an initial earnest money deposit in the amount of CAD $500,000 that will be credited toward the Purchase Price at the closing of the Purchase Agreement and is refundable only if the closing does not occur as a result of Seller’s default. On May 16, 2014, CCC paid an additional deposit in the amount of CAD $300,000 in consideration of an extension to the closing date to June 9, 2014 granted by the Sellers pursuant to an extension letter dated May 16, 2014 (the “Extension Letter”). On June 9, 2014, the Company paid an additional CAD $1,800,000 and on June 18, 2014 the Company paid an additional CAD $1,510,000.00, both payments to extend the closing date of the Purchase Agreement. The total deposits made by the Company to date with respect to the purchase of the Brampton Property is CAD $4,110,000, representing prepayment of approximately thirty and 67/100 percent (30.67%) of the total Purchase Prices for the Brampton Property.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10063084
Followers
|
19
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
410
|
Created
|
06/07/14
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |